Infection and upregulation of proinflammatory cytokines in human brain vascular pericytes by human cytomegalovirus

Journal of Neuroinflammation

Susan M Knobel¹  Hollie E Vigil¹  Wen Qin Zhu¹  Ashley M Charest¹  Donald J Alcendor¹ 

[1] Department of Microbiology and Immunology, Center for AIDS Health Disparities Research, Meharry Medical College, School of Medicine, 1005 Dr. D.B. Todd Jr. Blvd, Nashville, TN, 37208-3599, USA

关键词: cytokines;    virus replication;    blood–brain barrier;    neuroinflammation;    BMVECs;    astrocytes;    pericytes;    Cytomegalovirus;   

Others  :  1212610
DOI  :  10.1186/1742-2094-9-95

 received in 2011-11-13, accepted in 2012-04-24,  发布年份 2012

【 摘 要 】

Background

Congenital human cytomegalovirus (HCMV) infections can result in CNS abnormalities in newborn babies including vision loss, mental retardation, motor deficits, seizures, and hearing loss. Brain pericytes play an essential role in the development and function of the blood–brain barrier yet their unique role in HCMV dissemination and neuropathlogy has not been reported.

Methods

Primary human brain vascular pericytes were exposed to a primary clinical isolate of HCMV designated ‘SBCMV’. Infectivity was analyzed by microscopy, immunofluorescence, Western blot, and qRT-PCR. Microarrays were performed to identify proinflammatory cytokines upregulated after SBCMV exposure, and the results validated by real-time quantitative polymerase chain reaction (qPCR) methodology. In situ cytokine expression of pericytes after exposure to HCMV was examined by ELISA and in vivo evidence of HCMV infection of brain pericytes was shown by dual-labeled immunohistochemistry.

Results

HCMV-infected human brain vascular pericytes as evidenced by several markers. Using a clinical isolate of HCMV (SBCMV), microscopy of infected pericytes showed virion production and typical cytomegalic cytopathology. This finding was confirmed by the expression of major immediate early and late virion proteins and by the presence of HCMV mRNA. Brain pericytes were fully permissive for CMV lytic replication after 72 to 96 hours in culture compared to human astrocytes or human brain microvascular endothelial cells (BMVEC). However, temporal transcriptional expression of pp65 virion protein after SBCMV infection was lower than that seen with the HCMV Towne laboratory strain. Using RT-PCR and dual-labeled immunofluorescence, proinflammatory cytokines CXCL8/IL-8, CXCL11/ITAC, and CCL5/Rantes were upregulated in SBCMV-infected cells, as were tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1beta), and interleukin-6 (IL-6). Pericytes exposed to SBCMV elicited higher levels of IL-6 compared to both mock-infected as well as heat-killed virus controls. A 6.6-fold induction of IL-6 and no induction TNF-alpha was observed in SBCMV-infected cell supernatants at 24 hours postinfection. Using archival brain tissue from a patient coinfected with HCMV and HIV, we also found evidence of HCMV infection of pericytes using dual-label immunohistochemistry, as monitored by NG2 proteoglycan staining.

Conclusion

HCMV lytic infection of primary human brain pericytes suggests that pericytes contribute to both virus dissemination in the CNS as well as neuroinflammation.

【 授权许可】

   
2012 Alcendor et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

Figure 9.

【 参考文献 】

• [1]Boppana SB, Fowler KB, Pass RF, Rivera LB, Bradford RD, Lakeman FD, Britt WJ: Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr 2005, 146:817-823.
• [2]Colugnati FA, Staras SA, Dollard SC, Cannon MJ: Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis 2007, 7:71. BioMed Central Full Text
• [3]Sessions CF, Taeusch HW: Viral infections of the newborn. In Diseases of the newborn. Edited by Taeusch HW, Ballard RA, Avery ME. W. B. Saunders, Philadelphia; 1991:331-349.
• [4]Stagno S, Pass RF, Dworsky ME, Henderson RE, Moore EG, Walton PD, Alford CA: Congenital cytomegalovirus infection: the relative importance of primary and recurrent maternal infection. N Engl J Med 1982, 306:945-949.
• [5]Demmler GJ: Congenital cytomegalovirus infection and disease. Adv Pediatr Infect Dis 1996, 11:135-162.
• [6]Kylat RI, Kelly EN, Ford-Jones EL: Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection. Eur J Pediatr 2006, 165:773-778.
• [7]Cheeran CJ, Lokensgard JR, Schleiss MR: Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev 2009, 22:99-126.
• [8]Fowler K, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF: Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997, 130:624-630.
• [9]Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S: Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 2006, 35:216-220.
• [10]Tang HJ, Lui YC, Yen MY, Chen YS, Wann SR, Lin HH, Lee SS, Lin WR, Huang CK, Su BA, Chang PC, Li CM, Tseng HH: Opportunistic infections in adults with acquired immunodeficiency syndrome: a comparison of clinical and autopsy findings. J Microbiol Immunol Infect 2006, 4:310-315.
• [11]Arribas JR, Clifford DB, Fichtenbaum CJ, Commins DL, Powderly WG, Storch GA: Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. J Infect Dis 1996, 2:527-531.
• [12]Arribas JR, Storch GA, Clifford DB, Tselis AC: Cytomegalovirus encephalitis. Ann Intern Med 1996, 125:577-587.
• [13]Whitley RJ: Herpes simplex virus infections of the central nervous system. Encephalitis and neonatal herpes. Drugs 1991, 42:406-427.
• [14]Balladh P, Braun A, Nedergaard M: The blood–brain barrier: an overview, structure, regulation and clinical implications. NeuroBio Dis 2004, 16:1-13.
• [15]Englehardt B: Development of the blood–brain barrier. Cell Tissue Res 2002, 314:119-129.
• [16]Garberg P, Ball M, Borg N, Cecchelli R, Fenart L, Hurst RD, Lindmark T, Mabondzo A, Nilsson JE, Raub TJ, Stanimirovic D, Terasaki T, Oberg JO: In vitro models for the blood–brain barrier. Toxicol In Vitro 2005, 19:299-334.
• [17]Ramsauer M, Krause D, Dermietzel R: Angiogenesis of the blood–brain barrier in vitro and the function of cerebral pericytes. FASEB J 2002, 16:1274-1276.
• [18]Shepro D: Morel NM: Pericyte physiology. FASEB J. 1993, 7:1031-1038.
• [19]Tsukita S, Furuse M, Itoh M: Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001, 2:285-293.
• [20]Balabanov R, Dore-Duffy P: Role of CNS microvascular pericytes in the blood brain barrier. J Neurosci Res 1998, 53:637-644.
• [21]Dore-Duffy P: Pericytes: pluripotent cells of the blood brain barrier. Curr Pharm Des 2008, 16:1581-1593.
• [22]Dore-Duffy P, Cleary K: Morphology and properties of pericytes. Methods Mol Biol 2011, 686:49-68.
• [23]Lai CH, Kuo KH: The critical component to establish in vitro BBB model: pericyte. Brain Res Rev 2005, 50:258-265.
• [24]Price P, Eddy KS, Papadimitriou JM, Robertson TA, Shellam GR: Cytomegalovirus infection of adipose tissue induces steatitis in adult mice. Int J Exp Pathol 1990, 4:557-571.
• [25]Fiala M, Singer EJ, Commins D, Mirzapoiazova T, Verin A, Espinosa A, Ugen K, Bernas M, Witte M, Weinand M, Lossinsky AS: HIV-1 antigens in neurons of cocaine-abusing patients. Virol J 2008, 2:24-31.
• [26]Bryant P, Morley C, Garland S, Curtis N: Cytomegalovirus transmission from breast milk premature babies: does it matter? Arch Dis Child Feta Neonatal Ed 2002, 87:F75-F77.
• [27]Alcendor DJ, Knobel S: Identifying dysregulated genes induced by Kaposi’s sarcoma-associated herpesvirus (KSHV). J Vis Exp Sep 2010, 14:43. pii: 2078,
• [28]Ozerdem U, Grako KA, Dahlin-Huppe K, Monosov E, Stallcup WB: NG2 proteogylcan is expressed exclusively by mural cells during vascular morphogenesis. Dev Dyn 2001, 222:218-227.
• [29]Chin KC, Cresswell P: Viperin (CIG5), an IFN-inducible antiviral protein directly induced by cytomegalovirus. Proc Natl Acad Sci USA 2001, 98:15125-15130.
• [30]Olofsson PS, Jatta K, Wagsate D, Gredmark S, Hedin U, Paulsson-Berne G, Söderberg-Nauclér C, Hansson GK, Sirsjö A: The antiviral cytomegalovirus-inducible gene 5/viperin is expressed in atherosclerosis and regulated by proinflammatory agents. Arterioscler Thromb Vasc Biol 2005, 25:e113-e116.
• [31]Billstrom Schroeder M, Worthen GS: Viral regulation of Rantes expression during human cytomegalovirus infection of endothelial cells. J Virol 2001, 7:3383-3390.
• [32]Caposio P, Musso T, Luganini A, Inoue H, Gariglio M, Landolfo S, Gridaudo G: Targeting the NF-kappaB pathway through pharmacological inhibition of IKK2 prevents human cytomegalovirus replication and virus-induced inflammatory response in infected endothelial cells. Antiviral Res 2006, 3:175-184.
• [33]Cinati J, Kotchetkov R, Weimer E, Blaheta RA, Scholz M, Vogel JU, Gumbel HO, Doerr HW: The antisense oligonucleotide ISIS 2922 prevents cytomegalovirus-induced upregulation of IL-8 and ICAM-1 in cultured human fibroblasts. J Med Virol 2000, 3:313-323.
• [34]Alford CA, Britt WJ: Cytomegalovirus. Edited by Roizman B, Whitley RJ, Lopez C. Raven, New York; 1993:227-255.
• [35]Boppana SB, Fowler KB, Vaid Y, Hedlund G, Stagno S, Britt WJ, Pass RF: Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 1997, 9:409-414.
• [36]Cha TA, Tom E, Kemble GW, Duke GM, Mocarski ES, Spaete RR: Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 1996, 1:78-83.
• [37]MacCormac LP, Grundy JE: Two clinical isolates and the Toledo strain of cytomegalovirus contain endothelial cell tropic variants that are not present in the AD169, Towne, or Davis strains. J Med Virol 1999, 57:298-307.
• [38]Murphy E, Yu D, Grimwood J, Schmutz J, Dickson M, Jarvis MA, Hahn G, Nelson JA, Myers RM, Shenk TE: Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci USA 2003, 25:14976-14981.
• [39]Plachter B, Sinzger C, Jahn G: Cell types involved in replication and distribution of human cytomegalovirus. Adv Virus Res 1996, 46:195-261.
• [40]Sinzger C, Schmidt K, Knapp J, Kahl M, Beck R, Waldman J, Hebart H, Einsele H, Jahn G: Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J Gen Virol 1999, 80:2867-2877.
• [41]Ryckman BJ, Jarvis MA, Drummond DD, Nelson JA, Johnson DC: Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J Virol 2006, 80:710-722.
• [42]Cheeran MC, Hu S, Yager SL, Gekker G, Peterson PK, Lokensgard JR: Cytomegalovirus induces cytokines and chemokines production differentially in microglia and astrocytes: antiviral implications. J Neurovirol 2003, 7:135-147.
• [43]Kossmann T, Morganti-Kossmann Orenstein JM, Britt WJ, Wahl SM, Smith PD: Cytomegalovirus production by infected astrocytes correlates with transforming growth factor-beta release. J Infect Dis 2003, 187:534-541.
• [44]Lokensgard JR, Cheeran MC, Gekker G, Hu S, Chao CC, Peterson PK: Human cytomegalovirus replication and modulation of apoptosis in astrocytes. J Hum Virol 1999, 2:91-101.
• [45]Carlson JR, Chang WL, Zhou SS, Tarantal AF, Barry PA: Rhesus brain microvascular endothelial cells are permissive for rhesus cytomegalovirus infection. J Gen Virol 2005, 3:545-549.
• [46]Anderson AM, Fountain JA, Green SB, Bloom SA, Palmore MP: Human immunodeficiency virus-associated cytomegalovirus infection with multiple small vessel cerebral infarcts in the setting of early immune reconstitution. J Neurovirol 2010, 2:179-184.
• [47]Jellinger KA, Setinek U, Drlicek M, Bohm G, Steurer A, Lintner F: Neuropathology and general autopsy findings in AIDS during the last 15 years. Acta Neuropathol 2000, 2:213-220.
• [48]Myerson D, Hackman RC, Nelson JA, Ward DC, McDougall JK: Widespread presence of histologically occult cytomegalovirus. Hum Pathol 1984, 15:430-439.
• [49]Miller RF, Howard MR, Frith P, Perrons CJ, Pecorella I, Lucas SB: Herpesvirus infection of the eye and brain in HIV infected patients. Sex Transm Infect 2000, 4:282-286.
• [50]Jarvis M, Nelson JA: Human cytomegalovirus persistence and latency in endothelial cells and macrophages. Curr Opin Microbiol 2002, 5:403-407.
• [51]Lathey JL, Wiley CA, Verity MA, Nelson JA: Cultured human brain capillary endothelial cells are permissive for infection by human cytomegalovirus. Virology 1990, 1:266-273.
• [52]Stern JL, Slobedman B: Human cytomegalovirus latent infection of myeloid cells directs monocyte migration by up-regulating monocyte chemotactic protein-1. J Immunol 2008, 10:6577-6585.
• [53]Yurochko AD, Huang ES: Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression. J Immunol 1999, 162:4806-4816.
• [54]Kowalik TF, Wing B, Haskill JS, Azizkhan JC, Baldwin AS, Huang ES: Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Proc Natl Acad Sci USA 1993, 90:1107-1111.
• [55]Yurochko AD, Hwang ES, Rasmussen L, Keay S, Pereira L, Huang ES: The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-κB during infection. J Virol 1997, 71:5051-5059.
• [56]Yurochko AD, Mayo MW, Poma EE, Baldwin AS, Huang ES: Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-κB promoters. J Virol 1997, 71:4638-4648.
• [57]Johnson RA, Huong SM, Huang ES: Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38. J Virol 2000, 74:1158-1167.
• [58]Almeida-Porada G, Porada CD, Shanley JD, Ascensao JL: Altered production of GM-CSF and IL-8 in cytomegalovirus-infected, IL-1-primed umbilical cord endothelial cells. Exp Hematol 1997, 1997(25):1278-1285.
• [59]Gealy C, Denson M, Humphreys C, McSharry B, Wilkinson G, Caswell R: Posttranscriptional suppression of interleukin-6 production by human cytomegalovirus. J Virol 2005, 79:472-485.
• [60]Billstrom Schroeder M, Worthen GS: Viral regulation of RANTES expression during human cytomegalovirus infection of endothelial cells. J Virol 2001, 75:3383-3390.
• [61]Michelson S, Dal P, Dal Monte P, Zipeto D, Bodaghi B, Laurent L, Oberlin E, Arenzana-Seisdedos F, Virelizier JL, Landini MP: Modulation of RANTES production by human cytomegalovirus infection of fibroblasts. J Virol 1997, 71:6495-6500.
• [62]Baillie J, Sahlender DA, Sinclair JH: Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-α) signaling by targeting the 55-kilodalton TNF-α receptor. J Virol 2003, 77:7007-7016.
• [63]Hirsch AJ, Shenk T: Human cytomegalovirus inhibits transcription of the CC chemokine MCP-1 gene. J Virol 1999, 73:404-410.